Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256529 · ClinicalTrials.gov registry record
Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 483
- Enrollment target
NCT00256529: Completed study, sponsored by University of Utah.
NCT00256529 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 483 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00256529 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 483 participants
- Enrollment target
Study Summary
This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis (EoE) and to establish which presenting factors warrant esophageal biopsies. We hypothesize that a greater than expected percentage of patients who are biopsies will have histologic changes consistent with EE.
Interventions
- PROCEDURE EGD with biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2005-11 |
| Est. Completion | 2012-02 |
What the finished NCT00256529 record still lists
NCT00256529 is an observational study that tracks outcomes without assigning an intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which EGD with biopsies is the first listed.
NCT00256529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00256529 about?
NCT00256529 is a clinical study titled "Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia". This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis (EoE) and to establish which presenting factors warrant esophageal biopsies. We hypothesize that a greater than expected percentage...
What is the current status of trial NCT00256529?
This trial is currently completed. The enrollment target is 483 participants. The study started on 2005-11. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00256529?
The interventions under investigation include: EGD with biopsies (PROCEDURE).
Who is sponsoring clinical trial NCT00256529?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia